Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Rtw Biotech (RTW) Share Price

Price $2.43 on 24-07-2026 at 18:35:08
Change $-0.01 -0.41%
Buy $2.45
Sell $2.43
Last Trade: Sell 7,473.00 at $2.43
Day's Volume: 65,578
Last Close: $2.43
Open: $2.41
ISIN: GG00BKTRRM22
Day's Range $2.41 - $2.45
52wk Range: $1.295 - $2.48
Market Capitalisation: $783.24m
VWAP: $2.43602
Shares in Issue: 322.32m

Rtw Biotech (RTW) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 7,473 $2.43 Uncrossing Trade
16:35:26 - 24-Jul-26
Unknown* 165 $2.43 OTC Trade
16:29:55 - 24-Jul-26
Sell* 1 $2.43 SI Trade
16:27:09 - 24-Jul-26
Sell* 720 $2.44 Automatic Execution
16:20:22 - 24-Jul-26
Unknown* 760 $2.44 OTC Trade
16:20:22 - 24-Jul-26
Unknown* 165 $2.44 OTC Trade
16:20:22 - 24-Jul-26
Unknown* 3 $2.44 OTC Trade
16:16:11 - 24-Jul-26
Unknown* 15 $2.43 OTC Trade
16:10:35 - 24-Jul-26
Unknown* 90 $2.43 OTC Trade
16:06:02 - 24-Jul-26
Buy* 133 $2.45 Automatic Execution
16:01:37 - 24-Jul-26
See more Rtw Biotech trades

Rtw Biotech (RTW) Share Price History

Time period:
to
Date Open High Low Close Volume
23rd Jul 2026 (Thu) 2.46 2.47 2.43 2.44 189,335
22nd Jul 2026 (Wed) 2.43 2.48 2.42 2.48 262,850
21st Jul 2026 (Tue) 2.42 2.45 2.42 2.44 1,199,243
20th Jul 2026 (Mon) 2.43 2.44 2.41 2.44 55,222
17th Jul 2026 (Fri) 2.41 2.45 2.41 2.43 794,594
16th Jul 2026 (Thu) 2.40 2.43 2.39 2.43 188,019
15th Jul 2026 (Wed) 2.42 2.42 2.40 2.41 186,560
14th Jul 2026 (Tue) 2.40 2.41 2.35 2.41 263,401
13th Jul 2026 (Mon) 2.45 2.45 2.40 2.40 189,845
10th Jul 2026 (Fri) 2.44 2.44 2.39 2.43 136,864
9th Jul 2026 (Thu) 2.41 2.45 2.39 2.44 350,506
8th Jul 2026 (Wed) 2.38 2.45 2.35 2.45 309,749
7th Jul 2026 (Tue) 2.39 2.42 2.39 2.39 339,077
6th Jul 2026 (Mon) 2.39 2.44 2.38 2.40 434,841
3rd Jul 2026 (Fri) 2.42 2.44 2.40 2.43 188,197
2nd Jul 2026 (Thu) 2.40 2.47 2.39 2.47 178,526
1st Jul 2026 (Wed) 2.39 2.45 2.36 2.45 518,034
30th Jun 2026 (Tue) 2.38 2.43 2.38 2.42 1,134,460
29th Jun 2026 (Mon) 2.33 2.40 2.33 2.40 626,524
26th Jun 2026 (Fri) 2.33 2.37 2.27 2.33 1,108,029
25th Jun 2026 (Thu) 2.28 2.34 2.28 2.34 363,012
24th Jun 2026 (Wed) 2.19 2.30 2.19 2.30 3,797,550
See more Rtw Biotech price history

Rtw Biotech (RTW) Regulatory News

Date Source Headline
15th Jul 2026 7:00 am RNS Monthly Valuation Update and Factsheet
10th Jul 2026 7:00 am RNS Transaction in Own Shares
1st Jul 2026 7:01 am RNS Total Voting Rights
1st Jul 2026 7:00 am RNS Transaction in Own Shares
29th Jun 2026 7:00 am RNS Transaction in Own Shares
26th Jun 2026 7:00 am RNS Additional investment in Lycia Therapeutics
25th Jun 2026 7:01 am RNS Transaction in Own Shares
24th Jun 2026 7:00 am RNS Transaction in Own Shares
23rd Jun 2026 7:00 am RNS AbbVie to acquire Apogee Therapeutics
18th Jun 2026 7:00 am RNS Transaction in Own Shares
See more Rtw Biotech regulatory news

Rtw Biotech (RTW) Share News

RTW Biotech invests USD1.4 million in Lycia Therapeutics' series D

26th Jun 2026 09:51

(Alliance News) - RTW Biotech Opportunities Ltd on Friday said it has made an additional investment in portfolio company Lycia Therapeutics Inc as part of its series D financing round. Read More

WINNERS & LOSERS: Oil majors fall, airlines up on US-Iran peace hopes

12th Jun 2026 10:36

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday. Read More

UK shareholder meetings calendar - next 7 days

4th Jun 2026 12:27

Read More

IN BRIEF: RTW Biotech makes additional investment in Windward Bio

8th May 2026 10:59

RTW Biotech Opportunities Ltd - Guernsey-based investor in the life sciences sector - Invests USD1.7 million as part of portfolio company Windward Bio's USD165 million crossover financing. RTW Biotech says it first invested in the private, clinical-stage biotechnology company as part of its series A round back in January of last year. Notes that Windward Bio is focused on improving outcomes for people living with serious immunological diseases, with its lead programme WIN378 an antibody designed to treat asthma and chronic obstructive pulmonary disease. Read More

WINNERS & LOSERS: Intertek in red after latest EQT rejection

8th May 2026 10:46

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday. Read More

See more Rtw Biotech news
FTSE 100 Latest
Value10,736.23
Change97.06

Login to your account

Forgot Password?

Not Registered